TradeFlare's AI research teams analysed PRAX on 3 market nights between May 4, 2026 and August 31, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 31, 2026 | HOLD | $344.75 | — / — | +0.6% | -19.8% | The current market regime and stock-specific technicals do not support an immediate entry. |
| May 20, 2026 | HOLD | $320.61 | — / — | +5.1% | -15.9% | Positive clinical trial results for PRAX's lead drug candidates. |
| May 4, 2026 | HOLD | $324.20 | — / — | -1.7% | -23.6% | No clear catalyst identified for a bullish move given the current market regime and fundamental outlook. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.